Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
Abstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we exami...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-78364-5 |
id |
doaj-75c8d6bcd4f746f8a282c844bfc8dcbf |
---|---|
record_format |
Article |
spelling |
doaj-75c8d6bcd4f746f8a282c844bfc8dcbf2020-12-13T12:32:40ZengNature Publishing GroupScientific Reports2045-23222020-12-0110111510.1038/s41598-020-78364-5Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1David H. H. Molstad0Elizabeth Zars1Andrew Norton2Kim C. Mansky3Jennifer J. Westendorf4Elizabeth W. Bradley5Department of Orthopedics, University of MinnesotaDepartments of Orthopedic Surgery, Mayo ClinicDevelopmental and Surgical Sciences, University of MinnesotaDevelopmental and Surgical Sciences, University of MinnesotaDepartments of Orthopedic Surgery, Mayo ClinicDepartment of Orthopedics, University of MinnesotaAbstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we examined the functions of Hdac3 during bone healing. Conditional deletion of Hdac3 within myeloid progenitors accelerates healing of cortical bone defects. Moreover, reduced osteoclast numbers within the defect site are correlated with Hdac3 suppression. Ex vivo osteoclastogenesis assays further demonstrate that Hdac3 deficiency limits osteoclastogenesis, the number of nuclei per cell and bone resorption, suggesting a defect in cell fusion. High throughput RNA sequencing identified the transmembrane protein Pmepa1 as a differentially expressed gene within osteoclast progenitor cells. Knockdown of Pmepa1 partially restores defects in osteoclastogenesis induced by Hdac3 deficiency. These results show that Hdac3 is required for optimal bone healing and osteoclast fusion, potentially via its regulation of Pmepa1 expression.https://doi.org/10.1038/s41598-020-78364-5 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David H. H. Molstad Elizabeth Zars Andrew Norton Kim C. Mansky Jennifer J. Westendorf Elizabeth W. Bradley |
spellingShingle |
David H. H. Molstad Elizabeth Zars Andrew Norton Kim C. Mansky Jennifer J. Westendorf Elizabeth W. Bradley Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 Scientific Reports |
author_facet |
David H. H. Molstad Elizabeth Zars Andrew Norton Kim C. Mansky Jennifer J. Westendorf Elizabeth W. Bradley |
author_sort |
David H. H. Molstad |
title |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 |
title_short |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 |
title_full |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 |
title_fullStr |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 |
title_full_unstemmed |
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1 |
title_sort |
hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via pmepa1 |
publisher |
Nature Publishing Group |
series |
Scientific Reports |
issn |
2045-2322 |
publishDate |
2020-12-01 |
description |
Abstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we examined the functions of Hdac3 during bone healing. Conditional deletion of Hdac3 within myeloid progenitors accelerates healing of cortical bone defects. Moreover, reduced osteoclast numbers within the defect site are correlated with Hdac3 suppression. Ex vivo osteoclastogenesis assays further demonstrate that Hdac3 deficiency limits osteoclastogenesis, the number of nuclei per cell and bone resorption, suggesting a defect in cell fusion. High throughput RNA sequencing identified the transmembrane protein Pmepa1 as a differentially expressed gene within osteoclast progenitor cells. Knockdown of Pmepa1 partially restores defects in osteoclastogenesis induced by Hdac3 deficiency. These results show that Hdac3 is required for optimal bone healing and osteoclast fusion, potentially via its regulation of Pmepa1 expression. |
url |
https://doi.org/10.1038/s41598-020-78364-5 |
work_keys_str_mv |
AT davidhhmolstad hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 AT elizabethzars hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 AT andrewnorton hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 AT kimcmansky hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 AT jenniferjwestendorf hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 AT elizabethwbradley hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1 |
_version_ |
1724384660536950784 |